Mechanism and Assessment of Dyspnea

DEFINITION

PART 1: MECHANISMS OF DYSPNEA

A. General Principle - The Neuromechanical Dissociation Model

B. Three Physiologic Determinants (Guyton & Hall)

1. Abnormality of respiratory gases - hypercapnia (most potent stimulus) and, to a lesser extent, hypoxia
2. Increased work of breathing - the effort exerted by respiratory muscles to achieve adequate ventilation
3. State of mind - psychological and emotional factors (neurogenic/emotional dyspnea)

C. Neural Pathways and Receptor Inputs

D. The Three Distinct Sensory Qualities (ATS Language Framework)

E. Mechanisms by Organ System

1. Respiratory System

• Airway obstruction (asthma, COPD): increased work of breathing; dynamic hyperinflation; J-receptor activation
• Parenchymal disease (pneumonia, fibrosis): reduced compliance → ↑ work; stimulation of J-receptors; hypoxemia → peripheral chemoreceptor activation
• Pleural disease (effusion, pneumothorax): reduced lung volume, ↑ respiratory drive
• Neuromuscular disease (Guillain-Barré, myasthenia): reduced respiratory muscle strength → increased effort for given tidal volume

2. Cardiovascular System

• Heart failure: pulmonary venous hypertension → pulmonary edema → J-receptor stimulation; "air hunger"
  • Orthopnea: in the supine position, increased venous return to pulmonary vasculature + loss of gravitational diaphragmatic assistance → ↑ work of breathing
  • PND (paroxysmal nocturnal dyspnea): severe nocturnal dyspnea forcing the patient to sit/stand for gravitational fluid redistribution
• Pulmonary embolism: dead-space ventilation → V/Q mismatch → ↑ drive to breathe

3. Metabolic/Other

• Anemia: reduced O₂-carrying capacity → peripheral chemoreceptor/metaboreceptor stimulation → sense of "breathing more"
• Metabolic acidosis (diabetic ketoacidosis, salicylate overdose): Kussmaul breathing - deep, rapid respirations to compensate; despite appearing short of breath, patients may not subjectively feel dyspnea if sensorium is altered
• Deconditioning: early lactic acidosis during low-level exercise → ↑ ventilatory demand

4. Psychological/Neurogenic Dyspnea

• Anxiety, panic disorder → hyperventilation syndrome
• Dyspnea at rest that decreases with activity is often psychogenic
• Features: light-headedness, perioral/fingertip tingling, palpitations, T-wave changes on ECG, syncope

F. Central Processing - The Corollary Discharge Model

1. The respiratory muscles (motor command)
2. The sensory cortex (anticipatory signal of expected afferent feedback)

• Paralyzed patients on ventilation who are unable to trigger the ventilator experience severe dyspnea
• Constrained tidal volumes in ICU patients despite high respiratory drive produce intense air hunger

PART 2: ASSESSMENT OF DYSPNEA

A. History - Key Clinical Questions

1. Onset: acute vs. subacute vs. chronic
   • Acute (minutes-hours): PE, pneumothorax, acute asthma, acute MI, cardiac tamponade, pulmonary edema, foreign body aspiration
   • Subacute (days-weeks): pneumonia, pleural effusion, cardiac failure
   • Chronic (months-years): COPD, ILD, heart failure, anemia
2. Character/Quality: ask open-ended - which descriptor fits? (air hunger vs. chest tightness vs. effort) - helps identify physiology
3. Severity: at rest vs. on exertion; NYHA functional class; MRC dyspnea scale
4. Positional variation:
   • Orthopnea (supine worsening): left heart failure, bilateral diaphragmatic palsy
   • Platypnea (upright worsening): hepatopulmonary syndrome, ASD
   • Trepopnea (lateral position worsening): unilateral lung disease
5. Diurnal variation: nocturnal asthma, PND
6. Associated symptoms: cough, wheeze, haemoptysis, chest pain, fever, leg swelling, palpitations
7. Precipitants and relieving factors: allergens, cold air, exercise
8. Smoking history, occupational exposure
9. Response to bronchodilators (suggests reversible airway obstruction)

B. Psychometric Assessment of Dyspnea Intensity

1. Visual Analogue Scale (VAS)

• 100-mm horizontal line from "no breathlessness" to "worst imaginable breathlessness"
• Patient marks a point; the distance in mm is the score
• Used for acute dyspnea research; highly responsive

2. Borg Scale (CR10 / Modified Borg)

• Numerical scale 0-10 with verbal anchors (0 = nothing, 10 = maximum)
• Widely used during exercise testing (cardiopulmonary exercise test)
• Ratio scale - allows comparison of intensities

3. Medical Research Council (MRC) Dyspnea Scale

4. NYHA Functional Classification (Cardiac Dyspnea)

C. Multidimensional Assessment Tools

1. Dyspnea-12 (D-12)

• 12-item questionnaire covering both sensory (7 items) and affective (5 items) dimensions
• Each item scored 0-3; total 0-36
• Validated in COPD, pulmonary fibrosis, heart failure

2. Multidimensional Dyspnea Profile (MDP)

• Assesses immediate perception - overall unpleasantness, sensory quality, and emotional response
• Particularly useful in research settings

3. Baseline Dyspnea Index (BDI) and Transition Dyspnea Index (TDI)

• BDI: establishes baseline severity across three domains (functional impairment, magnitude of task, magnitude of effort)
• TDI: measures change from baseline - used to evaluate treatment response in COPD trials

4. Cancer Dyspnea Scale (CDS)

• 12-item scale for dyspnea in cancer patients; captures sense of effort, anxiety, and discomfort

D. Exercise Performance Assessment

1. Six-Minute Walk Test (6MWT)

• Patient walks as far as possible in 6 minutes on a flat corridor
• Minimum clinically important difference (MCID) ~30 m in COPD
• Correlates with mMRC grade and predicts mortality in COPD, heart failure, ILD

2. Cardiopulmonary Exercise Test (CPET)

• Gold standard for evaluation of exertional dyspnea
• Simultaneously measures pulmonary and cardiac function
• Identifies:
  • Ventilatory limitation (respiratory disease): breathing reserve exhausted at peak exercise
  • Cardiovascular limitation: heart rate reserve exhausted; O₂ pulse plateau
  • Deconditioning: early anaerobic threshold; no organ-specific limitation
  • Psychogenic dyspnea: normal all parameters; disproportionate symptoms
• Level 3 CPET (with arterial + pulmonary artery catheter): for diastolic heart failure, pulmonary hypertension

3. Shuttle Walk Test

• Incremental 10-metre shuttle test; more standardized than 6MWT
• Endurance shuttle walk test (ESWT): constant speed test for treatment response

E. Physical Examination in Dyspnea

F. Laboratory Assessment

G. Pulmonary Function Tests

• Spirometry (FEV₁, FVC, FEV₁/FVC): airway obstruction vs. restriction
  • FEV₁/FVC <0.7 post-bronchodilator = obstructive (COPD)
  • FVC↓ with normal ratio = restrictive pattern
  • Methacholine challenge: negative spirometry + high suspicion of asthma
• Lung volumes (TLC, RV, FRC): confirm restriction; assess hyperinflation in COPD
• DLCO (diffusing capacity): reduced in emphysema, ILD, pulmonary vascular disease, anemia
• MIP/MEP (maximal inspiratory/expiratory pressures): for suspected neuromuscular disease
• Flow-volume loop: upper airway obstruction (flattened inspiratory limb)

H. Quality of Life Assessment

• SGRQ (St. George's Respiratory Questionnaire): 50 items; domains: symptoms, activity, impacts; widely used in COPD/ILD; MCID = 4 points
• CRQ (Chronic Respiratory Questionnaire): 20 items; dyspnea, fatigue, mastery, emotional function
• MMRC + CAT (COPD Assessment Test): used in GOLD COPD staging (Group A-D)

KEY POINTS SUMMARY (for Exam)

1. Dyspnea = subjective, multidimensional experience of breathing discomfort; independent predictor of mortality
2. Core mechanism = neuromechanical dissociation + mismatch between efferent motor command and afferent feedback
3. Three physiologic drivers: hypercapnia > hypoxia, increased work of breathing, psychological state
4. Five distinct qualities map to different pathophysiology (air hunger, chest tightness, unsatisfying breath, effort, breathing more)
5. Assessment tools span multiple dimensions:
   • Intensity: VAS, Borg scale
   • Functional impact: MRC/mMRC, NYHA
   • Multidimensional: BDI/TDI, D-12, MDP
   • Exercise: 6MWT, CPET (gold standard for exertional dyspnea)
   • QoL: SGRQ, CRQ
6. BNP/NT-proBNP is the key biomarker to differentiate cardiac from pulmonary dyspnea
7. CPET is the gold standard for unexplained exertional dyspnea - can identify the limiting system